These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23277254)

  • 1. Eating-behavior changes associated with antipsychotic medications in patients with schizophrenia as measured by the drug-related eating behavior questionnaire.
    Ryu S; Nam HJ; Oh S; Park T; Lim M; Choi JS; Baek JH; Jang JH; Park HY; Kim SN; Joo YH; Kwon JS; Hong KS
    J Clin Psychopharmacol; 2013 Feb; 33(1):120-2. PubMed ID: 23277254
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patients.
    Sentissi O; Viala A; Bourdel MC; Kaminski F; Bellisle F; Olié JP; Poirier MF
    Int Clin Psychopharmacol; 2009 Sep; 24(5):257-64. PubMed ID: 19606055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotic disorders, eating habits, and physical activity: who is ready for lifestyle changes?
    Archie SM; Goldberg JO; Akhtar-Danesh N; Landeen J; McColl L; McNiven J
    Psychiatr Serv; 2007 Feb; 58(2):233-9. PubMed ID: 17287381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight gain among schizophrenic patients treated with clozapine.
    Lamberti JS; Bellnier T; Schwarzkopf SB
    Am J Psychiatry; 1992 May; 149(5):689-90. PubMed ID: 1349460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
    BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic.
    Ascher-Svanum H; Stensland MD; Kinon BJ; Tollefson GD
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):110-7. PubMed ID: 16280344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Weight gain and clozapine].
    Jalenques I; Tauveron I; Albuisson E; Audy V
    Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of weight gain on quality of life among persons with schizophrenia.
    Allison DB; Mackell JA; McDonnell DD
    Psychiatr Serv; 2003 Apr; 54(4):565-7. PubMed ID: 12663847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing symptom response among antipsychotic medications in CATIE.
    Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
    J Clin Psychopharmacol; 2013 Feb; 33(1):123-6. PubMed ID: 23288232
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study.
    Pae CU; Kim JJ; Lee KU; Lee CU; Bahk WM; Lee SJ; Lee C; Paik IH
    Hum Psychopharmacol; 2003 Aug; 18(6):453-6. PubMed ID: 12923823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight gain on antipsychotic medication is associated with sustained use among veterans with schizophrenia.
    Monnelly EP; Fonda J; Gagnon DR; Chittamooru S; Lawler EV
    J Clin Psychopharmacol; 2015 Feb; 35(1):57-62. PubMed ID: 25514067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is antipsychotic drug--induced weight gain associated with a favorable clinical response?
    Lamberti JS
    J Clin Psychiatry; 2000 Sep; 61(9):678. PubMed ID: 11030490
    [No Abstract]   [Full Text] [Related]  

  • 15. Subjective and biological weight-related parameters in adolescents and young adults with schizophrenia spectrum disorder under clozapine or olanzapine treatment.
    Bachmann CJ; Gebhardt S; Lehr D; Haberhausen M; Kaiser C; Otto B; Theisen FM
    Z Kinder Jugendpsychiatr Psychother; 2012 May; 40(3):151-8; quiz 158-9. PubMed ID: 22532107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 17. [Weight gain and antipsychotic drug treatment].
    Patri E; Dantchev N; Martinez M
    Encephale; 2000; 26(6):93-7. PubMed ID: 11217543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exercising caution in choice of psychotropic drugs. Avoid drug-induced weight gain].
    MMW Fortschr Med; 2002 May; Suppl 2():89. PubMed ID: 12070872
    [No Abstract]   [Full Text] [Related]  

  • 19. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
    Kao YC; Liu YP
    Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment.
    Barr AM; Procyshyn RM; Hui P; Johnson JL; Honer WG
    Schizophr Res; 2008 Mar; 100(1-3):252-60. PubMed ID: 18178062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.